
Pfizer Inc. announced Tuesday that a final analysis shows its experimental antiviral pill Paxlovid sharply reduced hospitalizations and deaths among people at high risk for severe illness. The latest results, which reinforce an earlier analysis released in November, show that Pfizer’s drug cut hospitalizations and deaths by nearly 90 percent when taken within three to… read on > read on >